Treating Hemophagocytic Lymphohistiocytosis (HLH)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Treating Hemophagocytic Lymphohistiocytosis (HLH)
-
ナレーター：
-
著者：
Dr Saara Kaviany and Dr Blachy J. Dávila Saldaña discuss the overall treatment goals and management strategies for patients with hemophagocytic lymphohistiocytosis (HLH). The discussion focuses on clinical considerations in HLH management, treatment goals, and factors clinicians may consider when evaluating patients with HLH.
This video features expert clinician discussion and is intended for US healthcare professionals.
Chapters
0:00 - HLH Treatment Goals and Management Overview
5:07 - Primary HLH Treatment Goals: Stabilization, Toxicity Reduction, and HSCT Preparation
10:40 - HSCT in Primary HLH: Treatment Pathway Considerations
18:43 - Initial HLH Treatment and Hyperinflammation Control
24:59 - HLH Treatment Risks and Clinical Considerations
30:01 - Targeted Treatment Approaches in HLH
35:17 - Key Takeaways for HLH Treatment Planning
Follow Us
- YouTube @Sobi-Pharma
- Linkedin @Sobi
Presented by Sobi Inc.
www.sobi.com
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.